[1] Lee L, Sanders RA.Metabolic syndrome.Pediatr Rev. 2012; 33(10):459-466.
[2] Xi B, He D, Hu Y,et al.Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009.Prev Med. 2013;57(6): 867-871.
[3] Kassi E, Pervanidou P, Kaltsas G,et al.Metabolic syndrome: definitions and controversies.BMC Med. 2011;9:48.
[4] Mahalle N, Garg MK, Naik SS, et al.Association of metabolic syndrome with severity of coronary artery disease.Indian J Endocrinol Metab. 2014;18(5):708-714.
[5] Farini A, Sitzia C, Erratico S,et al.Clinical applications of mesenchymal stem cells in chronic diseases.Stem Cells Int. 2014;2014:306573.
[6] Ruan GP, Han YB, Wang TH,et al.Comparative study among three different methods of bone marrow mesenchymal stem cell transplantation following cerebral infarction in rats.Neurol Res. 2013;35(2):212-220.
[7] Ruan GP, Xu F, Li ZA,et al.Induced autologous stem cell transplantation for treatment of rabbit renal interstitial fibrosis. PLoS One. 2013 Dec 18;8(12):e83507.
[8] Pan XH, Song QQ, Dai JJ,et al.Transplantation of bone marrow mesenchymal stem cells for the treatment of type 2 diabetes in a macaque model.Cells Tissues Organs. 2013; 198(6):414-427.
[9] Pan XH, Yang XY, Yao X,et al.Bone-marrow mesenchymal stem cell transplantation to treat diabetic nephropathy in tree shrews.Cell Biochem Funct. 2014;32(5):453-463.
[10] Ohishi M, Schipani E.Bone marrow mesenchymal stem cells.J Cell Biochem. 2010;109(2):277-282.
[11] Seo MS, Jeong YH, Park JR,et al.Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells.J Vet Sci. 2009;10(3):181-187.
[12] Nae S, Bordeianu I, St?ncioiu AT,et al.Human adipose-derived stem cells: definition, isolation, tissue-engineering applications.Rom J Morphol Embryol. 2013;54(4):919-924.
[13] Zucconi E, Vieira NM, Bueno DF,et al.Mesenchymal stem cells derived from canine umbilical cord vein--a novel source for cell therapy studies.Stem Cells Dev. 2010;19(3):395-402.
[14] De Schauwer C, Goossens K, Piepers S,et al. Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.Stem Cell Res Ther. 2014;5(1):6.
[15] Reaven GM.Insulin resistance: the link between obesity and cardiovascular disease.Med Clin North Am. 2011;95(5): 875-892.
[16] Hughey CC, Ma L, James FD,et al.Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart.Cardiovasc Diabetol. 2013; 12:128.
[17] Willenborg S, Eming SA.Macrophages - sensors and effectors coordinating skin damage and repair.J Dtsch Dermatol Ges. 2014;12(3):214-221.
[18] Hilhorst M, Shirai T, Berry G,et al.T cell-macrophage interactions and granuloma formation in vasculitis.Front Immunol. 2014;5:432.
[19] Johnson KE, Wilgus TA.Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair.Adv Wound Care (New Rochelle). 2014;3(10):647- 661.
[20] Shi Y, Su J, Roberts AI, et al.How mesenchymal stem cells interact with tissue immune responses.Trends Immunol. 2012; 33(3):136-143.
[21] Ma XL, Liu KD, Li FC,et al.Human mesenchymal stem cells increases expression of α-tubulin and angiopoietin 1 and 2 in focal cerebral ischemia and reperfusion.Curr Neurovasc Res. 2013;10(2):103-111.
[22] Aguilar S, Scotton CJ, McNulty K,et al.Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.PLoS One. 2009;4(11):e8013.
[23] Hung SP, Yang MH, Tseng KF,et al.Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression.Cell Transplant. 2013;22(10): 1869-1882.
[24] Kong P, Xie X, Li F, et al. Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats.Biochem Biophys Res Commun. 2013;438(2):410-419.
[25] Acosta SA, Franzese N, Staples M,et al.Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction.J Stem Cell Res Ther. 2013;(Suppl 4). pii: S4-005.
[26] Calafiore R, Montanucci P, Basta G.Stem cells for pancreatic β-cell replacement in diabetes mellitus: actual perspectives. Curr Opin Organ Transplant. 2014;19(2):162-168.
[27] Si Y, Zhao Y, Hao H, et al.Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes. 2012;61(6):1616-1625.
[28] Deuse T, Stubbendorff M, Tang-Quan K,et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.Cell Transplant. 2011;20(5): 655-667.
[29] Manochantr S, U-pratya Y, Kheolamai P,et al.Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.Intern Med J. 2013;43(4):430-439.
[30] Manochantr S, U-pratya Y, Kheolamai P, et al. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.Intern Med J. 2013;43(4):430-439.
[31] Kim YJ, Broxmeyer HE.Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.Crit Rev Oncol Hematol. 2011;79(2):112-126.
[32] Chhabra P, Brayman KL.Stem cell therapy to cure type 1 diabetes: from hype to hope.Stem Cells Transl Med. 2013; 2(5):328-336.
[33] Ji YR, Yang ZX, Han ZB,et al.Mesenchymal stem cells support proliferation and terminal differentiation of B cells.Cell Physiol Biochem. 2012;30(6):1526-1537.
[34] Shi Y, Hu G, Su J, et al.Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.Cell Res. 2010;20(5):510-518.
[35] 孔维霞,江小霞,毛宁.间充质干细胞的免疫调节功能及间充质干细胞在治疗自身免疫疾病中的应用[J].中国实验血液学杂志, 2009, 17(6): 1605-1608.
[36] Liu Y, Mu R, Wang S,et al.Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.Arthritis Res Ther. 2010;12(6):R210.
[37] Wang D, Li J, Zhang Y,et al.Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study.Arthritis Res Ther. 2014;16(2):R79.
[38] Sun L, Wang D, Liang J, et al.Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.Arthritis Rheum. 2010;62(8):2467-2475.
[39] Wu H, Mahato RI.Mesenchymal stem cell-based therapy for type 1 diabetes.Discov Med. 2014;17(93):139-143.
[40] Hu MJ, Ruan GP, Yao X,et al.Induced autologous stem cell transplantation for treatment of rabbit type 1 diabetes.Cell Biol Int. 2013;37(6):624-632.
[41] Sun J, Han ZB, Liao W,et al.Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors.Cell Physiol Biochem. 2011;27(5):587-596.
[42] Bassiouny AR, Zaky AZ, Abdulmalek SA,et al.Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.Int J Clin Exp Pathol. 2011; 4(7): 692-707. |